Trials / Conditions / Hereditary Hemochromatosis

Hereditary Hemochromatosis

10 registered clinical trials studyying Hereditary Hemochromatosis — 1 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	A Study to Evaluate BBI-001 in Healthy Volunteers and in Patients With Hereditary Hemochromatosis NCT07371793	Bond Biosciences	Phase 1 / Phase 2
Unknown	Quality and Biologic Characteristics of Red Blood Concentrates Obtained From Individuals With Elevated Ferriti NCT05742035	Interregionale Blutspende SRK	N/A
Terminated	A Study to Evaluate BBI-001 in Hereditary Haemochromatosis (HH) Patients and Iron Deficient Volunteers NCT05238207	Bond Biosciences	Phase 1
Completed	PTG-300 in Subjects With Hereditary Hemochromatosis NCT04202965	Protagonist Therapeutics, Inc.	Phase 2
Terminated	Study to Evaluate the Efficacy and Safety of Deferasirox Film-coated Tablet Versus Phlebotomy in Patients With NCT03203850	Novartis Pharmaceuticals	Phase 2
Completed	A Study of LJPC-401 for the Treatment of Iron Overload in Adult Patients With Hereditary Hemochromatosis NCT03395704	La Jolla Pharmaceutical Company	Phase 2
Unknown	Erythrocytapheresis Versus Phlebotomy as Maintenance Therapy in Hereditary Hemochromatosis (HH) Patients NCT01398644	Sanquin Research & Blood Bank Divisions	Phase 3
Completed	Safety and Efficacy of Deferasirox (ICL670) in Patients With Iron Overload Resulting From Hereditary Hemochrom NCT00395629	Novartis Pharmaceuticals	Phase 1 / Phase 2
Completed	Cardiac Function in Patients With Hereditary Hemochromatosis NCT00068159	National Heart, Lung, and Blood Institute (NHLBI)	—
Completed	Clinical Management of Hereditary Hemochromatosis: Phlebotomy vs. Erythrocytoapheresis NCT00440986	San Filippo Neri General Hospital	Phase 2 / Phase 3